Patents by Inventor Vincent Antle

Vincent Antle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sulfoalkyl ether cyclodextrin compositions
    Patent number: 8410077
    Abstract: SAE-CD compositions are provided, along with methods of making and using the same. The SAE-CD compositions comprise a sulfoalkyl ether cyclodextrin having an absorption of less than 0.5 A.U. due to a drug-degrading agent, as determined by UV/vis spectrophotometry at a wavelength of 245 nm to 270 nm for an aqueous solution containing 300 mg of the SAE-CD composition per mL of solution in a cell having a 1 cm path length.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: April 2, 2013
    Assignee: CyDex Pharmaceuticals, Inc.
    Inventor: Vincent Antle
  • Sulfoalkyl ether cyclodextrin compositions
    Patent number: 8383606
    Abstract: SAE-CD compositions are provided, along with methods of making and using the same. The SAE-CD compositions comprise a sulfoalkyl ether cyclodextrin having an absorption of less than 0.5 A.U. due to a drug-degrading agent, as determined by UV/vis spectrophotometry at a wavelength of 245 nm to 270 nm for an aqueous solution containing 300 mg of the SAE-CD composition per mL of solution in a cell having a 1 cm path length.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: February 26, 2013
    Assignee: CyDex Pharmaceuticals, Inc.
    Inventor: Vincent Antle
  • Sulfoalkyl Ether Cyclodextrin Compositions
    Publication number: 20100093663
    Abstract: SAE-CD compositions are provided, along with methods of making and using the same. The SAE-CD compositions comprise a sulfoalkyl ether cyclodextrin having an absorption of less than 0.5 A.U. due to a drug-degrading agent, as determined by UV/vis spectrophotometry at a wavelength of 245 nm to 270 nm for an aqueous solution containing 300 mg of the SAE-CD composition per mL of solution in a cell having a 1 cm path length.
    Type: Application
    Filed: November 5, 2009
    Publication date: April 15, 2010
    Applicant: CyDex Pharmaceuticals, Inc.
    Inventor: Vincent ANTLE
  • Sulfoalkyl ether cyclodextrin compositions
    Patent number: 7635773
    Abstract: SAE-CD compositions are provided, along with methods of making and using the same. The SAE-CD composition comprises a sulfoalkyl ether cyclodextrin and less than 100 ppm of a phosphate, wherein the SAE-CD composition has an absorption of less than 0.5 A.U. due to a drug-degrading agent, as determined by UV/vis spectrophotometry at a wavelength of 245 nm to 270 nm for an aqueous solution containing 300 mg of the SAE-CD composition per mL of solution in a cell having a 1 cm path length.
    Type: Grant
    Filed: March 13, 2009
    Date of Patent: December 22, 2009
    Assignee: CyDex Pharmaceuticals, Inc.
    Inventor: Vincent Antle
  • Sulfoalkyl Ether Cyclodextrin Compositions
    Publication number: 20090270348
    Abstract: SAE-CD compositions are provided, along with methods of making and using the same. The SAE-CD composition comprises a sulfoalkyl ether cyclodextrin and less than 100 ppm of a phosphate, wherein the SAE-CD composition has an absorption of less than 0.5 A.U. due to a drug-degrading agent, as determined by UV/vis spectrophotometry at a wavelength of 245 nm to 270 nm for an aqueous solution containing 300 mg of the SAE-CD composition per mL of solution in a cell having a 1 cm path length.
    Type: Application
    Filed: March 13, 2009
    Publication date: October 29, 2009
    Inventor: Vincent ANTLE